Advances in the study of immunopharmacological effects and mechanisms of extracts of Tripterygium wilfordii Hook. f. in neuroimmunologic disorders

Yaoxue Xuebao

Volumn 43, Issue 12, 2008, Pages 1179-1185

  Pan, Xiao Dong ^a   Chen, Xiao Chun ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

(5R) 5 hydroxytriptolide; Neurodegenerative; Neuroimmunology; Neuroinflammation; Tripchlorolide; Triptolide

Indexed keywords

5 HYDROXYTRIPTOLIDE; 5-HYDROXYTRIPTOLIDE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; DITERPENE; EPOXIDE; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHENANTHRENE DERIVATIVE; TRIPCHLOROLIDE; TRIPTOLIDE;

ANIMAL; CHEMISTRY; DEGENERATIVE DISEASE; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; REVIEW; STRUCTURE ACTIVITY RELATION; TRIPTERYGIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; DITERPENES; DRUGS, CHINESE HERBAL; EPOXY COMPOUNDS; HUMANS; NEURODEGENERATIVE DISEASES; NF-KAPPA B; PHENANTHRENES; STRUCTURE-ACTIVITY RELATIONSHIP; TRIPTERYGIUM;

EID: 57749189607     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Ma WG, Zhang T, Zhang C, et al. Study and prospect on venomous Tripterygium uiilfordii Hook. f. [J]. China J Tradit Chin Med Pharm, 2006,21: 117-120.
2. Lu X. The isolation and structure of tripchlorolide (T4) from Tripterygium, wilfordii [J]. J China Med Univ, 1990,12:157-161.
3. Zhou R, Zhang F, He PL, et al. (5R )-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo [J]. Int Immunopharmacol, 2005,5:1895-1903.
4. Wong KF, Chan JK, Chan KL, et al. Immunochemical characterization of the functional constituents of Tripterygium wilfordii contributing to its anti-inflammatory property [J]. Clin Exp Pharmacol Physiol, 2008, 35: 55-59.
5. Schumacher M, Guennoun R, Robert F, et al. Local synthesis and dual actions of progesterone in the nervous system; neuroprotection and myelination [J]. Growth Horm IGF Res, 2004,14:S18-33.
6. Zhang MM, Liu PL, Ye WY. Effect of Tripterygium wilfordii on adrenal cortex in rat with adjuvant arthritis [J]. J Tongji Med Univ, 1994, 14:158-161.
7. Wang YM, Zhang SL, Xia SX, et al. Toxicity of Tripterygium wilfordi [J]. Sichuan J Physiol Sci, 2008,30:28-31.
8. Zhang F, Li YC. Progress in structure modification of triptolide [J]. Acta Pharm Sin, 2004,39: 857-864.
9. Liu MX, Dong J, Yang YJ, et al. Preparation and toxicity of triptolide-loaded poly (D, L,-lactic acid ) nanoparticle [J]. Acta Pharm Sin, 2004, 39:556-560.
10. Walker DG, Lue LF. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases [J]. J Neurosci Res, 2005,81:412-425.
11. McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease; a review of 17 epidemiologic studies [J]. Neurology, 1996,47:425-432.
12. Lu C, Hu XL, Shi JQ, et al. GTW improves the behavioral impairment induced by beta-amyloid protein injected into hippocampus [J]. Chin J Behav Med Sci, 2005,14:39-40,52.
13. Lu C, Hu XL, Zhang XY, et al. Effects of Tripterygium wilfordii polylycosidium on responses of microglia induced by beta-amyloid protein injection in rat hippocampus [J]. Chin J Anat, 2005,28:225-226.
14. Gu M, Zhou HF, Xue B, et al. Effect of Chinese herb Tripterygium wilfordii Hook. f. monomer triptolide on apoptosis of PC12 cells induced by Abetal-42 [J]. Acta Physiol Sin, 2004,56:73-78.
15. Chen H, Zhang SM, Heman MA, et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease [J]. Arch Neurol, 2003,60:1059-1064.
16. Hong Z, Wang G, Gu J, et al. Tripchlorolide protects against MPTP-induced neurotoxicity in C57BL/6 mice [J]. Eur J Neurosci, 2007,26:1500-1508.
17. Cheng XX, Li FQ, Huang M, et al. Protective effect of tripchlorolide on dopaminergic neurons in partially lesioned rat model of Parkinson's disease [J]. Acta Pharm Sin, 2002,37:339-342.
18. Li FQ, Cheng XX, Liang XB, et al. Neurotrophic and neuroprotective effects of tripchlorolide, an extract of Chinese herb Tripterygium wilfordii Hook. f. , on dopaminergic neurons [J]. Exp Neurol, 2003,179:28-37.
19. Zhou HF, Liu XY, Niu DB, et al. Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection [J]. Neurobiol Dis, 2005,18:441-449.
20. Ramirez F, Mason D. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4 [J]. Eur J Immunol, 2000,30; 747-758.
21. Liu Y, Liu H, Ma TH, et al. The effect of combined injection of triptolide and dexamethasone on monocyte chemokine protein-1 in experimental autoimmune encephalomyelitis rat [J]. Chin J Neuroimmunol Neurol, 2006,13:73-76.
22. Fu YF, Zhu YN, Ni J, et al. (5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide derivative, prevents experimental autoimmune encephalomyelitis via inhibiting T cell activation [J]. J Neuroimmunol, 2006,175:142-151.
23. Wang Y, Mei Y, Feng D, et al. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis [J]. J Neurosci Res, 2008,86:2441-2449.
24. Zhang X, Xia JH. Effect of tripterygium polyglycoside on IL-6, sIL-2R of serum and cerebrospinal fluid in patients with Guillain-Barre syndrome [J]. Chin J Immunol, 2001,17:53-54.
25. Qiu D, Zhao G, Aoki Y, et al. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation [J]. J Biol Chem, 1999,274:13443-13450.
26. Xiao B, Shao HY, Xie GJ, et al. Roles of CD28/CTLA-4: B7 in EAN and response to Tripterygium wilfordii polypeptide (TWP) treatment [J]. Stroke Nerv Dis, 2001,8:67-70.
27. Zhou Y, Xiao B, Zhou WB. Roles of MCP-I in experimental autoimmune neuritis and response to TWP treatment [J]. Immunol J, 2007,23: 216-218.
28. Barone FC, Schmidt DB, Hillegass LM, et al. Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia [J]. Stroke, 1992, 23:1337-1347; discussion 1347-1338.
29. Bowes MP, Zivin JA, Rothlein R. Monoclonal antibody to the ICAM-I adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model [J]. Exp Neurol, 1993,119:215-219.
30. Stagliano NE, Dietrich WD, Prado R, et al. The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat [J]. Brain Res, 1997,759:32-40.
31. Wei DM, Huang GZ, Zhang YG, et al. Influence of triptolide on neuronal apoptosis in rat with cerebral injury after focal ischemia reperfusion [J]. China J Chin Mater Med, 2004,29:1089-1091,1116.
32. Tanaka K, Wada N, Ogawa N. Chronic cerebral hypoperfusion induces transient reversible monoaminergic changes in the rat brain [J]. Neurochem Res, 2000,25: 313-320.
33. Zhang Y, Jia DH, Liu ZW, et al. Effect of Tripterygium wilfordii polyglycosidium on monoamine neurotransmitters in rats with focal cerebral ischemia-reperfusion injury [J]. J Zhengzhou Univ (Med Sci) , 2005,40:1061-1064.
34. Li ZX, Zhang YL. Study on the variation of peripheral blood cellular immune of patients with myasthenia gravis after treatment with tripterygiitotorum [J]. Sichuan Med J, 2001,22:124-125.
35. Zhang JY, Peng F, Liu DH. The effects of Tripterygium on T lymphocyte subpopulation of myasthenia gravis patient [J]. Chin Med Rep, 2008,5: 80-81.
36. Lu GN, Zhou L, Xu JG. The effects of Tripterygium wilfordii polyglycosidium on neuromuscular junctions of adult toad [ ]. J West China Univ Med Sci, 1997,28:145-148.
37. Li KY, Lu GN, Zhang Y, et al. The effect of TWP on the reactivity of AChR on the end-plate membrane of frog sartorius [J]. J Sichuan Univ (Med Sci) , 2003,34:286-288.
38. Wang T, Zhang Y, Lu GN, et al. The effect of Tripterygium Wilfordii polyglycosidium on the compound action potential of skeletal muscle in experimental animals with myasthenia gravis [J]. J Sichuan Univ (Med Sei), 2004,35:379-381.
39. Pan XD, Chen XC, Zhu YG, et al. Neuroprotective role of tripchlorolide on inflammatory neurotoxicity induced by lipopolysaccharide-activated microglia [J]. Biochem Pharmacol, 2008,76:362-372.
40. Zhou R, Zheng SX, Tang W, et al. Inhibition of inducible nitric-oxide synthase expression by (5R)-S-hydroxytriptolide in interferon-γ and bacterial lipopolysaccharide-stimulated macrophages [J]. J Pharmacol Exp Ther, 2006,316:121-128.
41. 10 on glutamate induced PC 12 cell line damage and its mechanism [J]. J Peking Univ (Health Sci), 2003,35:252-255.
42. 10 against hydrogen peroxide-induced PC12 cell damage and its mechanism [J]. Chin J Neuromed, 2006,5:1194-1198.
43. Wu F, Wilson JX. Triptolide inhibits NADPH oxidase activity and iNOS expression in LPS + IFN-γ-stimulated microvascular endothelial cells [J]. FASEB J, 2007,21: 550.
44. Xue B, Jiao J, Zhang L, et al. Triptolide upregulates NGF synthesis in rat astrocyte cultures [J]. Neurochem Res, 2007,32:1113-1119.
45. Valerio A, Boroni F, Benarese M, et al. NF-kappaB pathway; a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production [J]. Eur J Neurosci, 2006,23:1711-1720.